CoreAge Rx vs GOAL.MD
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and GOAL.MD head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make GOAL.MD a bad call — it's best for readers who prefer authorizing each compounded refill and want to compare complete prepaid charges with shorter purchases. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | GOAL.MD |
|---|---|---|
| Brief Score | 94/100 (A) | 72/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $179/mo per order Compounded treatment, without automatic billing. Annual plan: $1,188 upfront ($99/mo equivalent). Brand-care fees exclude medication. Full price details$179/month compounded semaglutide without automatic billing; $1,188 upfront for the 12-month plan ($99/month equivalent) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $249/mo per order Compounded treatment, without automatic billing. Annual plan: $1,908 upfront ($159/mo equivalent). Brand-care fees exclude medication. Full price details$249/month compounded tirzepatide without automatic billing; $1,908 upfront for the 12-month plan ($159/month equivalent) |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises all 50 states, subject to state rules, clinical evaluation and pharmacy eligibility |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
GOAL.MD: Compounded plans are $179 semaglutide and $249 tirzepatide monthly; annual equivalents require $1,188/$1,908 upfront. The $95 brand-access fee excludes medication.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.